Scarica l'app Stockscreener
11.17
1.06%
-0.12
Dopo l'orario di chiusura:
11.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VIR Giù?
Forum
Previsione
Vir Biotechnology Inc Borsa (VIR) Ultime notizie
Vir Biotechnology, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer - biospace.com
Vir Biotechnology Appoints Aziz Sawaf as EVP and CFO - Contract Pharma
Vir Biotechnology names Aziz Sawaf as chief financial officer By Investing.com - Investing.com Canada
A $150K sign-on bonus, contingent on continued employment, awaits Vir Biotechnology (VIR)'s incoming CFO. - Stock Titan
Raymond James reiterates USD 19.00 target for Vir Biotechnology stock - AD HOC NEWS
Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Nears Key Hepatitis Delta Readout - Kalkine Media
Vir Biotechnology: Astellas Deal Highlights The Platform's Value - Seeking Alpha
Vir Biotechnology (VIR) Poised for Q4 ECLIPSE-1 Data Amid Strate - GuruFocus
(VIR) Risk Channels and Responsive Allocation - Stock Traders Daily
Bank of America Corp DE Acquires 1,142,539 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock falls 3.34 percent after Q2 results - AD HOC NEWS
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo! Finance Canada
Vir Biotechnology Stock Price Forecast. Should You Buy VIR? - StockInvest.us
Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring The 90.27% Potential Upside - DirectorsTalk Interviews
Engineers Gate Manager LP Sells 121,964 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
Former Vir (NASDAQ: VIR) officer sold $315K in stock, with more share sales planned - Stock Titan
Vir Biotechnology, Inc. $VIR Shares Acquired by Squarepoint Ops LLC - MarketBeat
Behavioral Patterns of VIR and Institutional Flows - Stock Traders Daily
WINTON GROUP Ltd Trims Stake in Vir Biotechnology, Inc. $VIR - MarketBeat
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership - Stocktwits
Vir Biotechnology (VIR) ex-officer to sell 28,333 shares from option exercise - Stock Titan
Vir Biotechnology (VIR) Pulls Back to $10.85 as Key Support at $10.31 Comes into FocusIchimoku TK Cross - careplusvn.com
How (VIR) Movements Inform Risk Allocation Models - Stock Traders Daily
Legal & General Group Plc Invests $2.76 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today? - Stocktwits
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of New York Mellon Corp Makes New $7.08 Million Investment in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on conference catalyst - ad-hoc-news.de
Man Group plc Takes $1.54 Million Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on new 52-week high and conference appearance - ad-hoc-news.de
Corient Private Wealth LP Invests $3.17 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Sets New 52-Week HighShould You Buy? - MarketBeat
Vir Biotechnology stock gains on conference participation and 52-week high - ad-hoc-news.de
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com South Africa
Vir Biotechnology stock hits 52-week high at 11.66 USD - investing.com
Vir Biotechnology (NASDAQ:VIR) Trading 4.8% HigherHere's What Happened - MarketBeat
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Deutsche Bank AG Acquires Shares of 134,258 Vir Biotechnology, Inc. $VIR - MarketBeat
ARCH Venture Management LLC Invests $129.35 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Algert Global LLC Purchases 315,969 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
ADAR1 Capital Management LLC Acquires New Shares in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ: VIR) ex-officer lines up more sales - Stock Titan
Vir Biotechnology: Late-Stage CHD Progress and Astellas Partnership Strengthen Growth Outlook - kalkine.ca
Vir Biotechnology (NASDAQ: VIR) officer plans 14,352-share sale after 25K sale - Stock Titan
Vir Biotechnology (NASDAQ: VIR) ex-officer files notice for potential $245K stock sale - Stock Titan
Vir Biotechnology on Track for Record Winning Streak -- Data Talk - Bitget
Vir (VIR) Close and Levels: Adds 1.06% to Close at $9.49 in the Latest Reading; Key Levels: the $9.02 to $9.96 Range Remains in Focus in Latest TradingRevenue Weighted - vinanet.vn
The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability - Sahm
Vir Biotechnology’s Earnings Call Signals Data-Driven Momentum - TipRanks
Vir Biotechnology Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Vir Biotechnology (VIR) Climbs 2.67% to $9.24 as Trading Volume Picks UpETH Profile - vinanet.vn
Vir Biotechnology (VIR) Q2 2026 Earnings Call Transcript - The Globe and Mail
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):